SAN FRANCISCO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) will showcase some of the latest innovations designed to help clinicians in the treatment of cardiovascular disease at the 2023 Transcatheter Cardiovascular Therapeutics conference (TCT) which will take place October 23-26 in San Francisco, CA. In modern healthcare today, cardiovascular disease (CVD) continues to…
Click here to view original post